Skip to main content

Table 5 CETP Taq I B frequencies in T2DM patients and controls after subdividing according to age

From: Association of CETP TaqI and APOE polymorphisms with type II diabetes mellitus in North Indians: a case control study

GENOTYPE

AGE (YEAR)

(PATIENT NO./CONTROL NO.)

P-VALUE

OR (95% CI)

B1B1

Upto 30 (2/12)

0.599

2.000 (0.298–13.435)

 

31–45 (15/23)

0.836

0.923 (0.430–1.980)

 

46–60 (21/18)

0.186

1.650 (0.783–3.479)

 

Above 60 (2/19)

0.481

0.433 (0.085–2.206)

B1B2

Upto 30 (3/28)

1.000

1.071 (0.164–7.014)

 

31–45 (34/41)

0.243

1.508 (0.756–3.009)

 

46–60 (27/40)

0.288

0.694 (0.354–1.363)

 

Above 60 (8/23)

0.054

3.826 (0.916–15.984)

B2B2

Upto 30 (0/8)

1.000

-

 

31–45 (7/17)

0.199

0.538 (0.207–1.398)

 

46–60 (14/18)

0.879

0.940 (0.424–2.084)

 

Above 60 (1/14)

0.433

0.300 (0.035–2.557)